Oncology

Headache Relief Shampoo Voted #1 Best New Product in 2019

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019 / by / in
A Pilot Study of BXCL701 in Patients With Pancreatic Cancer
Conditions:   Cancer of Pancreas;   Cancer of the Pancreas;   Neoplasms, Pancreatic;   Pancreas Cancer;   Pancreatic Cancer
Intervention:   Drug: Talabostat Mesylate
Sponsors:   BioXcel Therapeutics Inc;   IQVIA Biotech
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 18, 2019 / by / in
Phase 1 Study to Determine the MTD, Safety, Tolerability, PK and Preliminary Anti-tumor Effects of LNS8801
Conditions:   Solid Tumor, Adult;   Lymphoma
Intervention:   Drug: Small molecule, orally bioavailable, selective agonist of GPER
Sponsor:   Linnaeus Therapeutics, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 18, 2019 / by / in
Azacitidine Plus Nivolumab Following Reduced-intensity Allogeneic PBSC Transplantation for Patients With AML and High-risk Myelodysplasia
Conditions:   Aml;   AML, Adult
Interventions:   Drug: Nivolumab;   Drug: Azacitidine
Sponsor:   Sherif Farag
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 17, 2019 / by / in
The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
Condition:   Breast Cancer
Interventions:   Drug: Tamoxifen Citrate;   Drug: Letrozole;   Drug: Exemestane;   Diagnostic Test: Blueprint;   Diagnostic Test: Mammaprint
Sponsors:   Johns Hopkins University;   Agendia
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 17, 2019 / by / in
Study of AMV564 in Subjects With Advanced Solid Tumors
Condition:   Locally Advanced or Metastatic Solid Tumors
Intervention:   Biological: AMV564
Sponsor:   Amphivena Therapeutics, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 17, 2019 / by / in
A Study of Zanubrutinib (BGB-3111) in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment With Ibrutinib
Condition:   Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Intervention:   Drug: Zanubrutinib
Sponsor:   BeiGene
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 17, 2019 / by / in
Effect of Addition of Steroids on Duration of Analgesia
Conditions:   Uterine Fibroids;   Adenomyosis
Interventions:   Drug: Triamcinolone;   Drug: Bupivacaine;   Other: Iohexol contrast
Sponsor:   University of North Carolina, Chapel Hill
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 16, 2019 / by / in
Telomere Associated Variables (TAVs) in Prostate Cancer
Condition:   Prostate Cancer
Intervention:  
Sponsor:   Life Length SL
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 15, 2019 / by / in
Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families
Conditions:   Hereditary Breast Carcinoma;   Hereditary Ovarian Carcinoma;   Lynch Syndrome;   Mutation Carrier
Interventions:   Behavioral: Behavioral Dietary Intervention;   Other: E-mail;   Behavioral: Exercise Intervention;   Other: Internet-Based Intervention;   Other: Questionnaire Administration;   Behavioral: Telephone-Based Intervention;   Other: Text Message
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 15, 2019 / by / in
Post-contracture Release Radiation for Dupuytren’s Disease
Conditions:   Dupuytren’s Disease;   Dupuytren Contracture;   Dupuytren Disease of Palm and Finger;   Dupuytren Disease of Finger;   Dupuytrens Contracture of Both Hands;   Dupuytren’s Disease of Palm of Right Hand;   Dupuytren’s Disease of Palm of Left Hand;   Dupuytren Contracture of Right Palm;   Dupuytren Contracture of Left Palm;   Dupuytren’s Contracture Left;   Dupuytren’s Contracture Right
Intervention:   Other: Evaluation of Dupuytren’s Disease Treatment
Sponsor:   University of Minnesota – Clinical and Translational Science Institute
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 11, 2019 / by / in